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Background Recent cases of laboratory-acquired vaccinia virus (VV) infection highlight the need for laboratory
safety.
Aims To determine laboratory worker adherence to the Advisory Committee for Immunization Practices
smallpox vaccination recommendations, assess potential barriers to vaccination and determine the
inﬂuence of training on laboratory worker attitudes.
Methods Ninety-two laboratory workers in Pennsylvania were contacted and asked to complete an online
survey about VV usage; 45 responded.
Results Eighty-seven per cent had received a smallpox vaccination in their lifetime; 73% received vaccination
in the past 10 years. More workers had been given training regarding the potential risks, versus the
potential beneﬁts of vaccination, and most perceived that adverse outcomes were more likely to occur
following vaccination versus accidental infection.
Conclusions The results of this study suggest that the main barrier to vaccination may be fear associated with pos-
sible vaccine adverse effects and a willingness to risk accidental infection rather than be vaccinated.
More information and training about the potential beneﬁts of vaccination, as well as the potential
adverse outcomes associated with accidental infection, is therefore warranted.
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Introduction
As the ﬁelds of molecular biology and vaccine develop-
ment have expanded, the use of vaccinia virus (VV) as
a molecular tool has become increasingly common [1].
However, despite its utility, VV is a potentially hazardous
pathogen and laboratory workers should have the neces-
sary tools and information to protect themselves against
accidental infection.
In recognition of this, the Advisory Committee on
Immunization Practices (ACIP) has recommended vacci-
nation with smallpox vaccine (ACAM2000, Acambis) for
the prevention of VV infection among laboratory workers
[2] in the USA. In addition, biosafety guidelines recom-
mendtheuseofpersonalprotectiveequipment(PPE)[3].
Recent cases oflaboratory-acquiredVV infection high-
light the need for a greater understanding of the knowl-
edge, attitudes and practices of laboratory workers
handling VV [4]. The purpose of this study was therefore
to determine adherence to ACIP recommendations,
assess potential barriers to vaccination and determine
the inﬂuence of training on laboratory worker attitudes.
Methods
This investigation was conducted as part of a public health
responsefollowinganaccidentalVVinfectioninaPennsyl-
vania laboratory worker. (This activity was deemed non-
research in accordance with agency interpretation of the
US Code of Federal Regulations, Title 45, Part 46, which
setsforthregulationsfortheprotectionofhumansubjects.)
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were identiﬁed by the Centers for Disease Control and
Prevention and the Pennsylvania Department of Health.
In March of 2005, letters were sent to the occupational
health and safety directors of each identiﬁed institution
(n 5 16), requesting the email addresses of employees
who, in the past 5 years, had worked in laboratories that
utilize VV. Five of 16 institutions contacted during the in-
vestigation declined to participate, citing that VV was not
currently being utilized in their laboratories. Ninety-two
eligible workers were identiﬁed, contacted and asked to
complete an online survey to evaluate their knowledge,
attitudes and practices regarding smallpox vaccination.
Investigators were blinded to names and email addresses
of prospective subjects to protect anonymity. Contact
information was stored separately from responses. No in-
formation was retained for those who declined to partic-
ipate. The survey contained 42 structured questions with
aseries of response options provided. Dataweremanaged
and summarized using SPSS.
Results
Forty-ﬁve (49%) workers responded to the survey
(Table 1). Eighty-seven per cent of respondents had re-
ceived a smallpox vaccination in their lifetime; 73%
received vaccination in the past 10 years. Sixty per cent
of respondents worked with non-highly attenuated strains
of VV. Of these, seven had not received vaccination in the
past 10 years. The non-vaccinated respondents (n 5 5)
were all afﬁliated with universities. No information was
recorded for eligible laboratory workers who declined
participation.
Although 89% of respondents reported being aware of
contraindications to smallpox vaccine, 21% of those who
had been vaccinated had contraindications, including
skin conditions and immune compromise (Table 2).
Nearly, all who responded (96%) had received training
on the risks of working with live VVand the risks of small-
poxvaccine.Respondentswhohadnotbeenvaccinatedin
thepast10yearsreceived less trainingthanthosewhohad
been vaccinated in the past 10 years.
Respondents perceived that speciﬁc adverse outcomes
were more likely to occur following vaccination versus ac-
cidental infection, namely, ‘swelling of glands’ (91 versus
51%), ‘feeling bad enough to miss work’ (53 versus 29%)
and ‘accidental infection of a contact’ (26 versus 13%).
Respondents were more concerned about vaccine side-
effects than accidental infection, although 31% of
respondents knew someone who was infected by VV
due to a laboratory accident.
Among those who were ever vaccinated, 59% reported
their primaryreason for receiving vaccination as ‘required
by institution’. Seventy-six per cent reported that ‘con-
cern for personal safety’ was the strongest inﬂuence on
their adherence to safe laboratory practices. Ninety-ﬁve
per cent of respondents thought that people who work
with VV should be required to follow safety guidelines
and wear PPE. When asked why workers do not wear
PPE, 55% respondents reported ‘don’t think it’s
Table1. Characteristics of all respondents, vaccinated respondents
and non-vaccinated respondents
Characteristics All,
n (%)
Vaccinated,
n (%)
Non-vaccinated,
n (%)
Respondents 45
a (100) 39 (87) 5 (11)
Institution 44
a 38 5
University 25 (57) 20 (53) 5 (100)
Industry 17
a (39) 16 (42) 0
Private 2 (5) 2 (5) 0
Occupation 44
a 38 5
Laboratory
director
12 (27) 12 (32) 0
Graduate
student
9 (21) 6 (16) 3 (60)
Laboratory
technician
7 (16) 6 (16) 1 (20)
Staff scientist 6 (14) 6 (16) 0
Postdoctoral
researcher
4 (9) 4 (11) 0
Instructor/
non-tenure
3 (7) 2 (5) 1 (20)
Other 3
a (7) 2 (5) 0
Age 44
a 38 5
.37 years 18 (41) 16 (42) 2 (40)
33–37 years 8
a (18) 5 (13) 2 (40)
,33 years 18 (41) 17 (45) 1 (20)
aIncludes one with unknown vaccination status.
Table 2. Awareness of contraindications and presence of contrain-
dications among all respondents, vaccinated respondents and non-
vaccinated respondents
Characteristics All,
n (%)
Vaccinated,
n (%)
Non-vaccinated,
n (%)
Respondents 45
a 39 5
Aware of
contraindications
40 (89) 37 (95) 3 (60)
Have contraindications 11 (24) 8 (21) 3 (60)
Work with non-highly
attenuated strains
9 (82) 6 (75) 3 (100)
Immunodeﬁciency 7 (64) 6 (75) 1 (33)
Skin condition 9 (82) 7 (88) 2 (67)
Pregnant/
breastfeeding
5 (46) 5 (63) 0
Cardiac disease 3 (27) 3 (38) 0
Contact with infant 5 (46) 5 (63) 0
Close contact having
contraindications
5 (46) 5 (63) 0
aIncludes one with unknown vaccination status.
76 OCCUPATIONAL MEDICINEnecessary’, 48% reported ‘limits visibility or dexterity’,
36% reported ‘lack of availability’ and 14% reported
‘implies lack of laboratory skill’.
Forty-eight per cent of respondents agreed that
laboratory workers who handle VV should be required
to receive smallpox vaccination. Most (81%) agreed
that people who have contraindications for smallpox
vaccination should be discouraged from working with
live VV.
Discussion
Although most laboratory workers in this study received
vaccination, more than a quarter of those who handled
non-highly attenuated strains had not been vaccinated
in the past 10 years.
Despite the fact that a majority of respondents
reported an awareness of contraindications to vaccine,
and agreed that workers with contraindications should
be discouraged from working with VV, .20% of vacci-
nated workers themselves had contraindications. More-
over, most of the workers with contraindications
manipulated non-highly attenuated strains (Table 2).
Over 90% of respondents received training on the risks
of working with VV and how to protect oneself from
accidental infection. Despite the amount of training re-
ceived, however, respondents remained unclear about
the biosafety levels associated with VV work and out-
comes of accidental infection. All the most senior workers
(identiﬁed as laboratory directors, staff scientists or post-
doctoral workers) received vaccination, highlighting the
special considerations posed for student and temporary
workerswhomayperceivethattheywillderivelessbeneﬁt
from vaccination due to the transient nature of their VV
research activities.
A comparison of accidental VV infection among vac-
cinated versus non-vaccinated cases revealed that those
who had never been vaccinated had more serious out-
comes, including hospitalization [4–10]. Such examples
may help to better inform laboratory workers about the
beneﬁts of vaccination.
This studyis limitedbyaweakresponserate andbythe
clustering of participants according to institution. Addi-
tionally, not all participants responded to all questions.
Despite these limitations, the ﬁndings can help to guide
future safety recommendations for laboratory workers
who handle VV.
In order to formulate effective policy, it is critical to
obtain insight into the prevailing beliefs and practices
of the population to which such policy is targeted. The
results of this study reveal a lack of adherence to current
recommendations of the ACIP, a need for greater training
of laboratory workers who handle VV and that institu-
tional policies are important in ensuring the safety of lab-
oratory workers through vaccination.
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Key points
• The results of this study reveal a lack of adherence
to current smallpox vaccination recommendations
and suggest a need for greater training of labora-
tory workers who handle vaccinia virus.
• Among laboratory workers who manipulate vac-
cinia virus, the main barrier to receiving smallpox
vaccination may be fear associated with possible
vaccine adverse effects and a willingness to risk ac-
cidental infection rather than be vaccinated.
• The results of this study suggest that institutional
policies can play a major role in ensuring the safety
of laboratory workers through vaccination.
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